Back
Apellis Pharmaceuticals Stock Predictions
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
19
APLS
Apellis Pharmaceuticals
Last Price:
$17.30
Seasonality Move:
-4.83%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Apellis Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 14.2% based on the past 7 years of stock performance.
-
Apellis Pharmaceuticals has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
-
Is Apellis Pharmaceuticals Stock Undervalued?The current Apellis Pharmaceuticals [APLS] share price is $17.30. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Apellis Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 14.2% based on the past 7 years of stock performance.
Apellis Pharmaceuticals Stock Rating
Sell
19
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals overpriced?
-
Apellis Pharmaceuticals has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
Apellis Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apellis.com
52-Week Data
52-Week High:
43.99
52-Week Low:
16.65
Prediction Charts
Market Cap:
2.2B
Price in USD:
17.30
Volume:
3M
Beta:
0.94
Technical Analysis
SMA50:
21.53
SMA100:
26.04
SMA200:
29.57
52-Wk Change:
-59.31%
Stock Predictions
-
Is Apellis Pharmaceuticals stock public?Yes, Apellis Pharmaceuticals is a publicly traded company.
-
What is the Apellis Pharmaceuticals stock quote today?The Apellis Pharmaceuticals stock price is 17.30 USD today.
-
How to buy Apellis Pharmaceuticals stock online?You can buy Apellis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-22 | 18.22 | 17.37 | 18.36 | 17.02 |
| Apr-23 | 17.93 | 17.49 | 18.36 | 17.46 |
| Apr-24 | 17.60 | 17.54 | 17.95 | 17.29 |
| Apr-25 | 17.35 | 17.49 | 17.59 | 16.98 |
| Apr-28 | 17.55 | 17.96 | 18.19 | 17.52 |
| Apr-29 | 18.02 | 18.21 | 18.47 | 17.90 |
| Apr-30 | 18.14 | 19.21 | 19.21 | 17.76 |
| May-1 | 19.00 | 20.08 | 20.49 | 18.52 |
| May-2 | 20.31 | 20.34 | 20.75 | 20.09 |
| May-5 | 20.30 | 19.98 | 20.59 | 19.81 |
| May-6 | 19.76 | 19.12 | 20.18 | 18.99 |
| May-7 | 17.16 | 17.99 | 19.32 | 16.65 |
| May-8 | 17.81 | 17.81 | 18.32 | 17.35 |
| May-9 | 17.52 | 17.30 | 18.10 | 17.24 |
Apellis Pharmaceuticals Earnings
Apellis Pharmaceuticals Earnings Report: Per Share Apellis Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Apellis Pharmaceuticals Forecast Revenue Growth
Apellis Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Apellis Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.20 per share, a decrease this year of $0.20 per share, and an increase next year of $1.30 per share.
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.